Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4khn | XG4 | DNA-directed DNA polymerase |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4khn | XG4 | DNA-directed DNA polymerase | / | 1.000 | |
1clq | GDP | DNA-directed DNA polymerase | / | 0.520 | |
4i9q | XG4 | DNA-directed DNA polymerase | / | 0.507 | |
1waj | 5GP | DNA-directed DNA polymerase | / | 0.485 | |
3cfo | GMP | DNA-directed DNA polymerase | / | 0.474 | |
4h6p | FMN | Chromate reductase | / | 0.454 | |
2xys | SY9 | Soluble acetylcholine receptor | / | 0.451 | |
1k4g | AIQ | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.449 | |
2v2z | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.448 | |
1nbi | SAM | Glycine N-methyltransferase | 2.1.1.20 | 0.447 | |
2b82 | ADN | Class B acid phosphatase | 3.1.3.2 | 0.443 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
1q6n | P90 | Tyrosine-protein phosphatase non-receptor type 1 | 3.1.3.48 | 0.442 | |
2vt4 | P32 | Beta-1 adrenergic receptor | / | 0.442 | |
3ziu | LSS | Leucyl-tRNA synthetase | / | 0.442 |